Chord Energy CHRD 深 沪
已收盘 10-16 16:00:00 美东时间
154.56
+6.230
+4.20%
华盛通- 最 高154.90
- 今 开149.70
- 成交量 80.90万股
- 最 低 149.25
- 昨 收 148.33
- 总市值 84.54亿
- 52周最高 157.06
- 市盈率 静 209.29
- 换手率 1.48%
- 52周最低 79.045
- 委 比 -71.78%
- 总股本 5469.79万
- 历史最高 174.23
- 量 比 1.42
- 振 幅 3.81%
- 历史最低 -63.635
- 每 手 1
- 风险率 22.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
If You Invested $1000 In Chord Energy Stock 10 Years Ago, You Would Have This Much Today
Chord Energy (NASDAQ:CHRD) has outperformed the market over the past 10 years by 14.97% on an annualized basis producing an average annual return of 28.71%. Currently, Chord Energy has a market capitalization of $7.44 billion. Buying $1000 In CHRD: If an investor had bought $1000 of CHRD stock 10 ye...
10-09 07:30
美股大行评级 | 花旗看高AMD至800美元！富国上调Meta目标价至1000美元
今日重点评级关注：Jones Trading：维持Opus Genetics"买入"评级，目标价从10美元升至17美元；Citizens：维持Rezolute"跑赢大市"评级，目标价从11美元升至15美元
10-07 17:30
美股大行评级 | 瑞银维持康宁“买入”评级，上调目标价至201美元；大摩维持泛林集团“超配”评级
今日重点评级关注：Needham：维持iRhythm Holdings"买入"评级，目标价从192美元升至194美元；HC Wainwright & Co.：维持5E Advanced Materials"买入"评级，目标价从3.5美元升至6.75美元
10-06 16:45
Chord Energy Releases 2025 Sustainability Report
HOUSTON, Oct. 2, 2026 /PRNewswire/ -- Chord Energy Corporation (NASDAQ: CHRD) ("Chord" or the "Company") today announced the release of its 2025 Sustainability Report, which highlights Chord...
10-02 21:00
Here’s How Much You Would Have Made Owning Chord Energy Stock In The Last 10 Years
Chord Energy (NASDAQ:CHRD) has outperformed the market over the past 10 years by 14.64% on an annualized basis producing an average annual return of 28.24%. Currently, Chord Energy has a market capitalization of $7.35 billion. Buying $1000 In CHRD: If an investor had bought $1000 of CHRD stock 10 ye...
10-01 00:45
美股大行评级 | Muse热度发酵，Meta目标价获大幅升至875美元；闪迪获看好至2400美元，潜在升幅约27%
今日重点评级关注：Citizens：上调Quince Therapeutics评级至"跑赢大市"，目标价77美元；康托·菲茨杰拉德：维持塞德斯医疗"超配"评级，目标价从61美元升至72美元
09-23 15:30
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
美股大行评级 | 赛富时获多家机构上调目标价，最高至300美元！谷歌获看多至450美元，仍有3成上涨空间
今日重点评级关注：Canaccord Genuity：维持Generac Holdings"买入"评级，目标价从275美元升至375美元；巴克莱：维持Oscar Health"超配"评级，目标价从39美元升至49美元
09-18 16:18
Citigroup Maintains Neutral on Chord Energy, Raises Price Target to $150
Citigroup analyst Paul Diamond maintains Chord Energy (NASDAQ:CHRD) with a Neutral and raises the price target from $130 to $150.
09-17 21:44
